US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 17:22:47 Source：Cosmic Chronicle news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at
- Next：OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
Related articles
- Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
- Rough return to 'normal' sends Scheffler down the leaderboard at PGA Championship
- Arsenal are seen REHEARSING their Premier League trophy presentation
- Israel announces reopening of Kerem Shalom crossing with Gaza
- What's next for Iran after death of its president in crash?
- China auto association slams US protectionism in NEV industry
- Chinese FM spokesperson briefs on new round of China
- Contreras hits 3
- Burglar hurled stolen mobile phones at police from the top of 60ft high roof during nine
- Heartbreak as Tyson Fury is defeated by Oleksandr Usyk in the fight of the century
- What a blast to work at NASA. Space agency is sky
- Man shoots his 6
- 2 shot dead on outskirts of Paris
- Tesla's new mega factory project in Shanghai granted construction permit
- Burglar hurled stolen mobile phones at police from the top of 60ft high roof during nine
- Kate Moss snubs Buckingham Palace garden party after failing to turn up to star
- A man investigated in the deaths of women in northwest Oregon has been indicted in 3 killings
- China's top diplomat holds talks with Peru's foreign minister
- Nadal returns to Roland Garros to practice amid doubts over fitness and form
- Suzhou Symphony Orchestra embarks on Algeria tour
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Cosmic Chronicle news portal sitemap